CRN supports FDA action against marketing pure powdered caffeine to consumers FDA approves updated labeling for Simponi Aria McKesson public policy forum encourages pharmacists to get involved FDA unveils draft guidance for naming biosimilars FDA approves Synjardy tablets E-prescribing controlled substances now legal nationwide NACDS honors two chains for political advocacy Educating policy-makers to effect Rx change ‘Show me’ payments spawn risk-sharing efforts Insurers adapt to market-style coverage approach First Previous 56 57 58 59 60 Next Last
